September 8-11 2015
Helping pharma and biotech accelerate their future drug development with a fully defined and robust CDx strategy – World CDx Boston delivers end to end roadmap for pharma and biotech to successfully understand the true heterogeneity of disease, validate translational and predictive biomarkers and implement a robust CDx strategy to increase the efficacy and value of their drug candidates.
The 6th Annual World CDx Boston Summit continues to guide drug, diagnostic and technology developers all the way from early clinical development and translational biomarker validation to market launch of drug-CDx combinations. The World CDx Community will once again assemble to align drug-CDx co-development, showcase the most ground-breaking clinical trial results and refine personalized healthcare for targeted patient populations. More>
“World CDx was a fantastic event both in terms of the science and the networking opportunities."
- Oscar Puig, Biomarker Leader, Oncology, Roche